BioHealth News Archive
Three biotechs reveal some secrets about themselves as they gun for $271M-plus in IPOs – Endpoints News
Last week ended with another Friday night blitz of biotech S-1s as a fresh wave of new offerings forms to crash into Nasdaq. Entering…
Read MoreUniversities earned just $75 million from IP in 2017, but spent $5.7 billion on R&D: Report – The Logic
Canada’s top universities and research institutes spent $5.7 billion on research and development (R&D), but generated less than $75 million from licensing their innovations…
Read MoreHow Redox Is Transforming The Way Healthcare Providers Share Data
Redox, a Madison, Wisconsin-based healthcare technology company that is transforming the way healthcare providers and software vendors share data, announced it has raised $33…
Read MoreY Combinator to fund more startups pursuing small-molecule drugs – STAT
The startup incubator Y Combinator plans to fund more early-stage drug makers, with a partnership designed to bring academic spinouts developing small-molecule drugs into…
Read MoreUnited Therapeutics Announces FDA Approval Of XPS™ And Steen Solution™ Used To Perform Centralized Ex-Vivo Lung Perfusion Services | BioSpace
United Therapeutics Corporation (Nasdaq: UTHR) today announced that its collaborator, XVIVO Perfusion, Inc., a subsidiary of XVIVO Perfusion AB (STO: XVIVO), has received Premarket…
Read MoreGSK receives US approval of Benlysta for intravenous use in children with lupus aged five years and above | Antibodies | News Channels
GSK today announced that the US Food and Drug Administration (FDA) has approved, under priority review, the use of the intravenous (IV) formulation of…
Read MoreSirnaomics closes Series C funding round – Washington Business Journal
Sirnaomics Inc. has taken in yet another $11 million in investments, closing a Series C funding round that totaled $47 million. {iframe}https://www.bizjournals.com/washington/news/2019/04/26/sirnaomics-closes-47-million-funding-round.amp.html{/iframe}
Read MoreUniversity Of Maryland Medical School Uses New Drone To Transport Donor Organs – CBS Baltimore
A pioneering medical breakthrough that will help organ transplant recipients was announced by the University of Maryland Medical School. Drone technology was developed by…
Read MoreKite’s CAR-T manufacturing gets another boost with new Maryland facility | FiercePharma
With an FDA approval for its pricey CAR-T therapy Yescarta under its belt and more treatments in the pipeline, Gilead’s Kite Pharma was on…
Read MoreTHRIVE 2019: CREATING THE FUTURE OF BIOSCIENCE IN VIRGINIA
Every two years leader of the life science industry gather from across the state to connect, celebrate, learn, inspire, imagine, and drive forward the…
Read MoreGSK ramps up investment into Shingrix production
GSK announces that it will spend $100m to expand production capacity for components of Shingrix, amid a US market where demand outstrips supply of…
Read MoreKite Pharma plans manufacturing facility in Frederick County – Technical.ly Baltimore
A Santa Monica, Calif.-based biopharmaceutical company plans to open a facility where it will produce cell therapy treatments in Maryland’s Frederick County. Kite Pharma…
Read MoreIBBR investigator to lead $3.5M NIH-funded project to study immune response to HIV-1
Researchers at the Institute for Bioscience and Biotechnology Research (IBBR) recently received $3.5M from the National Institutes of Health (NIH) to advance understanding of…
Read MoreBuilt For Bio: Pat Larrabee, President of Facility Logix
MCEDC learns how Pat’s love for science drove her to found a company in Montgomery County, MD that delivers the cutting-edge buildings innovators need…
Read MoreAutolus Therapeutics Receives FDA Orphan Drug Designation for AUTO3 for Treatment of Acute Lymphoblastic Leukemia Nasdaq:AUTL
Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies for the treatment of cancer, announced that the United States…
Read More